Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Equity (2016 - 2025)

Ptc Therapeutics has reported Return on Equity over the past 13 years, most recently at 3.08% for Q4 2025.

  • Quarterly results put Return on Equity at 3.08% for Q4 2025, up 272.0% from a year ago — trailing twelve months through Dec 2025 was 3.08% (up 272.0% YoY), and the annual figure for FY2025 was 0.85%, up 45.0%.
  • Return on Equity for Q4 2025 was 3.08% at Ptc Therapeutics, up from 4.0% in the prior quarter.
  • Over the last five years, Return on Equity for PTCT hit a ceiling of 3.08% in Q4 2025 and a floor of 4.0% in Q3 2025.
  • Median Return on Equity over the past 5 years was 0.23% (2023), compared with a mean of 0.25%.
  • Biggest five-year swings in Return on Equity: soared 333bps in 2022 and later plummeted -368bps in 2025.
  • Ptc Therapeutics' Return on Equity stood at 0.68% in 2021, then soared by 403bps to 2.06% in 2022, then tumbled by -110bps to 0.21% in 2023, then soared by 271bps to 0.36% in 2024, then soared by 750bps to 3.08% in 2025.
  • The last three reported values for Return on Equity were 3.08% (Q4 2025), 4.0% (Q3 2025), and 3.07% (Q2 2025) per Business Quant data.